| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |